NCPC has obtained the drug registration certificate for injectable vancomycin hydrochloride (0.5g)
I'm PortAI, I can summarize articles.
NCPC recently obtained the drug registration certificate for injectable Vancomycin Hydrochloride (0.5g) approved by the National Medical Products Administration. This certificate indicates that the product meets the basic access conditions for centralized procurement bidding and has an efficacy equivalent to the original research product, further improving the company's product structure in the field of anti-infection
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments